News & Analysis on Clinical Trial Services & Contract Research And Development
An oral drug developed to treat the common cold that was rejected for approval by the US Food and Drug Administration last year could find a new lease of life in an oral formulation, according to its developer. If this is correct, the drug could...
A pilot study supported by the European Commission has concluded that a lack of access to scientific equipment and technology, and not salaries, is one of the main factors causing the 'brain drain' of scientists, often from developing countries to the...
The high cost of some of the compounds kept in pharmaceutical company libraries has driven a move towards the use of smaller and smaller quantities of samples in both in storage and high-throughput screening.
Three individuals have been formally charged in the US for their alleged involvement in the counterfeiting of Pfizer's Lipitor (atorvastatin) as investigators try to unravel the intricate web of conspirators behind the case.
The new agreement between BioProgress and an unnamed US over-the-counter pharmaceuticals firm could double the UK company's capacity to manufacture cellulose films for drug encapsulation, according to chief executive Graham Hind.
TTP Labtech gave the first European demonstration of the high-throughput version of its mosquito liquid-handling system, designed to cope with the tiny quantities of reagents used in the new generation of 1536-well plates, this week at the...